No Image

CBD Producers Jumping the Pond to Capitalize on Potential Multi-Billion-Dollar EU CBD Market

NEW YORK, June 14, 2019 /PRNewswire/ — Much has changed in the aftermath of the World Health Organization’s (WHO) marijuana reclassification recommendation back in February — in particular, the potential for the European Union (EU) CBD market. Products made from the non-psychoactive cannabinoid are growing in popularity in the EU, through innovation and perseverance from North American companies such as StillCanna Inc. (CSE:STIL) (OTCPK:SCNNF), Marijuana Company of America, Inc. (OTCQB:MCOA), ICC International Cannabis Corp. (OTCPK: WLDCF) (CSE: WRLD.U), OrganiGram Holdings Inc. (NASDAQ: OGI) (TSX. V:OGI) and Aleafia Health Inc. (OTCQX: ALEAF) (TSX: ALEF).






No Image

Sunniva Inc. Announces Voting Results From 2019 Annual General And Special Meeting Of Shareholders

VANCOUVER, British Columbia, June 13, 2019 /PRNewswire/ — Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders held on June 12, 2019. A total of 16,195,196 common shares, representing approximately 42% of the Company’s issued and outstanding common shares, were voted in connection with the meeting. Shareholders voted in favour of all items of business put forth by way of show of hands. The votes for the election of directors per the proxies received were as follows:


No Image

Chemistree Comments on Recent Promotional Activity at Request of OTC Markets

VANCOUVER, June 13, 2019 /PRNewswire/ – Chemistree Technology Inc. (CSE: CHM) (US OTCQB: CHMJF) (the “Company” or “Chemistree”), has been requested by OTC Markets Group to comment on recent promotional activity. The Company first became aware of certain promotional third-party newsletter activities through a notification by OTC Markets on June 11, 2019.


No Image

Abacus CEO Perry Antelman to Speak at the Inaugural Institutional Capital & Cannabis Conference Europe

WOONSOCKET, RI, June 13, 2019 /CNW/ – Abacus Health Products (“Abacus” or the “Company”) (CSE: ABCS) CEO Perry Antelman will be a panel participant at the inaugural Institutional Capital & Cannabis Conference Europe (IC3 Europe) to be held in London, England, on June 26, 2019. The panel session, “The Path to Public Markets”, will offer insights on the journeys of public companies in North America.